"intercept" "in pathway" "intercept" "experimental" "in clinical development" "targeted" "unknown" "lambdaf" "lambdad"
"NIG1" 3.12456327904835 NA 89.71814391787 NA NA NA NA 4.23597438898727 12.8756567040837
"NIG2" 3.1773945391182 0.588805226687883 96.2162496653473 10.979732495113 3.89114980957081 -15.7669897784229 -11.8588783627374 4.62657064307691 15.1205290447588
"NIG3" 41.6438306446439 1.5010644488679 NA NA NA NA NA 0.141797334836712 NA
"NIG4" NA NA 130.646592281355 6.66720064752339 0.286798126795297 -8.95030218323156 -10.2789236761975 NA 15.1205290447588
"lasso" 3.1773945391182 0.588805226687883 96.2162496653473 10.979732495113 3.89114980957081 -15.7669897784229 -11.8588783627374 4.62657064307691 15.1205290447588
"bSEM" 296.56122704228 -31.2216304963686 NA NA NA NA NA NA NA
